HR-1520 : Became Public Law

Purple Book Continuity Act of 2019

This bill modifies requirements for the Food and Drug Administration to publish information regarding biological products.

Action Timeline

Action DateTypeTextSource
2020-12-22PresidentBecame Public Law No: 116-246.Library of Congress
2020-12-22PresidentSigned by President.Library of Congress
2020-12-21FloorPresented to President.House floor actions
2020-12-21FloorMessage on Senate action sent to the House.Senate
2020-12-21ResolvingDifferencesSenate agreed to the House amendment to the Senate amendment to H.R. 1520 by Voice Vote. (consideration: CR S7923)Senate
2020-12-21FloorMessage on House action received in Senate and at desk: House amendment to Senate amendment.Senate
2020-12-21FloorHouse agreed to the Senate amendment with an amendment pursuant to the provisions of H.Res. 1271. (consideration: CR H7300; text of amendment in the nature of a substitute: CR H7300)House floor actions
2020-12-11FloorMessage on Senate action sent to the House.Senate
2020-12-10FloorPassed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7396-7397)Senate
2020-12-10FloorMeasure laid before Senate by unanimous consent. (consideration: CR S7396-7397)Senate
2020-12-10DischargeSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.Senate
2019-05-09IntroReferralReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Senate
2019-05-08FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2019-05-08VoteOn motion to suspend the rules and pass the bill, as amended Agreed to by recorded vote (2/3 required): 421 - 0 (Roll no. 188). (text: CR H3485-3486)House floor actions
2019-05-08FloorConsidered as unfinished business. (consideration: CR H3491-3492)House floor actions
2019-05-08FloorAt the conclusion of debate, the chair put the question on the motion to suspend the rules. Ms. Eshoo objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.House floor actions
2019-05-08FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 1520.House floor actions
2019-05-08FloorConsidered under suspension of the rules. (consideration: CR H3485-3486)House floor actions
2019-05-08FloorMs. Eshoo moved to suspend the rules and pass the bill, as amended.House floor actions
2019-05-03CalendarsPlaced on the Union Calendar, Calendar No. 26.House floor actions
2019-05-03CommitteeReported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-48.House floor actions
2019-04-03CommitteeOrdered to be Reported (Amended) by Voice Vote.House committee actions
2019-04-03CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2019-03-27CommitteeForwarded by Subcommittee to Full Committee (Amended) by Voice Vote .House committee actions
2019-03-27CommitteeSubcommittee Consideration and Mark-up Session Held.House committee actions
2019-03-06CommitteeReferred to the Subcommittee on Health.House committee actions
2019-03-05IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2019-03-05IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Economics and Public Finance
See Subjects
  • Appropriations
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Executive agency funding and structure
  • Government information and archives
  • Licensing and registrations

Related Bills

See Related Bills